Literature DB >> 24930826

Validity, reliability, and assessment sensitivity of the Japanese version of the short-form McGill pain questionnaire 2 in Japanese patients with neuropathic and non-neuropathic pain.

Tomoyuki Maruo1, Aya Nakae, Lynn Maeda, Kenrin Shi, Kayoko Takahashi, Shayne Morris, Koichi Hosomi, Hiroshi Kanatani, Taiga Matsuzaki, Youichi Saitoh.   

Abstract

OBJECTIVE: The objective of this study was to define the validity, reliability, and assessment sensitivity of the Japanese version of the Short-Form McGill Pain Questionnaire 2 (SF-MPQ-2-J).
DESIGN: This is a cross-sectional study. PATIENTS AND METHODS: The original SF-MPQ-2 was translated into Japanese to create the SF-MPQ-2-J, and the cross-cultural equivalence of assessment tool for Japanese patients was validated. The reliability of the SF-MPQ-2-J was assessed using internal consistency, reliability coefficients (Cronbach's α), and reproducibility coefficients (intraclass correlation coefficient) obtained using 234 patients with chronic pain. SF-MPQ-2-J validity was assessed based on associations identified between total and subscale scores compared with other assessment methods. A confirmatory factor analysis (CFA) was also performed to test the theoretical structure of the SF-MPQ-2-J.
RESULTS: The internal consistencies calculated included continuous pain, α=0.893; intermittent pain, α=0.875; predominantly neuropathic pain, α=0.917; affective descriptors, α=0.857; and total score, α=0.907. The reproducibility coefficients calculated included continuous pain, ρ=0.81; intermittent pain, ρ=0.78; predominantly neuropathic pain, ρ=0.85; affective descriptors, ρ=0.75; and total score, ρ=0.83. The CFA showed that the model fit of the readily interpretable subscales was acceptable, and the goodness of fit index value was 0.917. In addition, the mean predominantly neuropathic pain subscale score was found to be significantly higher for patients with neuropathic pain vs non-neuropathic pain.
CONCLUSION: These findings suggest that the reliability and validity of the SF-MPQ-2-J are excellent, and the SF-MPQ-2-J represents a cross-cultural equivalent to SF-MPQ-2. Consequently, the latter is suitable for research and clinical use, and for discriminating neuropathic pain from non-neuropathic pain. Wiley Periodicals, Inc.

Entities:  

Keywords:  Neuropathic Pain; Reliability and Validity; Short-Form McGill Pain Questionnaire 2

Mesh:

Year:  2014        PMID: 24930826     DOI: 10.1111/pme.12468

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  18 in total

1.  Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.

Authors:  Hiromichi Matsuoka; Satoru Iwase; Tempei Miyaji; Takashi Kawaguchi; Keisuke Ariyoshi; Shunsuke Oyamada; Eriko Satomi; Hiroto Ishiki; Hideaki Hasuo; Hiroko Sakuma; Akihiro Tokoro; Yoshinobu Matsuda; Kazuki Tahara; Hiroyuki Otani; Yoichi Ohtake; Hiroaki Tsukuura; Yoshihisa Matsumoto; Yoshikazu Hasegawa; Yuki Kataoka; Masatomo Otsuka; Kiyohiro Sakai; Miki Nakura; Tatsuya Morita; Takuhiro Yamaguchi; Atsuko Koyama
Journal:  Support Care Cancer       Date:  2019-11-25       Impact factor: 3.603

2.  Induced sensorimotor brain plasticity controls pain in phantom limb patients.

Authors:  Takufumi Yanagisawa; Ryohei Fukuma; Ben Seymour; Koichi Hosomi; Haruhiko Kishima; Takeshi Shimizu; Hiroshi Yokoi; Masayuki Hirata; Toshiki Yoshimine; Yukiyasu Kamitani; Youichi Saitoh
Journal:  Nat Commun       Date:  2016-10-27       Impact factor: 14.919

3.  A cross-cultural adaptation and validation of the short-form McGill Pain Questionnaire-2: Chinese version in patients with chronic visceral pain.

Authors:  Jiang-Lin Wang; Wei-Jun Zhang; Min Gao; Shengfa Zhang; Dong-Hua Tian; Jun Chen
Journal:  J Pain Res       Date:  2017-01-05       Impact factor: 3.133

4.  Psychometric Properties of Sinhala Version of Short-Form McGill Pain Questionnaire-2 (SF MPQ-2-Sin) among Patients with Cancer Pain in Sri Lanka.

Authors:  Nirosha P Edirisinghe; Thamasi R Makuloluwa; Thamara D Amarasekara; Christine S E Goonewardena
Journal:  Pain Res Manag       Date:  2019-10-08       Impact factor: 3.037

5.  A randomized controlled trial of 5 daily sessions and continuous trial of 4 weekly sessions of repetitive transcranial magnetic stimulation for neuropathic pain.

Authors:  Koichi Hosomi; Kenji Sugiyama; Yusaku Nakamura; Toshio Shimokawa; Satoru Oshino; Yuko Goto; Tomoo Mano; Takeshi Shimizu; Takufumi Yanagisawa; Youichi Saitoh
Journal:  Pain       Date:  2020-02       Impact factor: 7.926

6.  Can Wound Exudate from Venous Leg Ulcers Measure Wound Pain Status?: A Pilot Study.

Authors:  Taichi Goto; Nao Tamai; Gojiro Nakagami; Aya Kitamura; Ayumi Naito; Masayuki Hirokawa; Chisako Shimokawa; Kazuo Takahashi; Junichi Umemoto; Hiromi Sanada
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

7.  Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.

Authors:  Hiromichi Matsuoka; Hiroto Ishiki; Satoru Iwase; Atsuko Koyama; Takashi Kawaguchi; Yoshiyuki Kizawa; Tatsuya Morita; Yoshinobu Matsuda; Tempei Miyaji; Keisuke Ariyoshi; Takuhiro Yamaguchi
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

8.  Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).

Authors:  Hiromichi Matsuoka; Junji Tsurutani; Yasutaka Chiba; Yoshihiko Fujita; Masato Terashima; Takeshi Yoshida; Kiyohiro Sakai; Yoichi Otake; Atsuko Koyama; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  BMC Cancer       Date:  2017-10-06       Impact factor: 4.430

9.  MEG-BMI to Control Phantom Limb Pain.

Authors:  Takufumi Yanagisawa; Ryohei Fukuma; Ben Seymour; Koichi Hosomi; Haruhiko Kishima; Takeshi Shimizu; Hiroshi Yokoi; Masayuki Hirata; Toshiki Yoshimine; Yukiyasu Kamitani; Youichi Saitoh
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-07-12       Impact factor: 1.742

10.  Burst Spinal Cord Stimulation for the Treatment of Cervical Dystonia with Intractable Pain: A Pilot Study.

Authors:  Takeshi Shimizu; Tomoyuki Maruo; Shimpei Miura; Yuki Kimoto; Yukitaka Ushio; Satoshi Goto; Haruhiko Kishima
Journal:  Brain Sci       Date:  2020-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.